Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Epigenetic landscape change analysis during human EMT sheds light on a key EMT mediator TRIM29.

Choi SK, Pandiyan K, Eun JW, Yang X, Hong SH, Nam SW, Jones PA, Liang G, You JS.

Oncotarget. 2017 Oct 9;8(58):98322-98335. doi: 10.18632/oncotarget.21681. eCollection 2017 Nov 17.

2.

TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells.

Shinohara N, Maeda S, Yahiro Y, Sakuma D, Matsuyama K, Imamura K, Kawamura I, Setoguchi T, Ishidou Y, Nagano S, Komiya S.

Sci Rep. 2017 Oct 18;7(1):13494. doi: 10.1038/s41598-017-13994-w.

3.

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer.

Legras A, Pécuchet N, Imbeaud S, Pallier K, Didelot A, Roussel H, Gibault L, Fabre E, Le Pimpec-Barthes F, Laurent-Puig P, Blons H.

Cancers (Basel). 2017 Aug 3;9(8). pii: E101. doi: 10.3390/cancers9080101. Review.

4.
5.

hsa-miR-485-5p reverses epithelial to mesenchymal transition and promotes cisplatin-induced cell death by targeting PAK1 in oral tongue squamous cell carcinoma.

Lin XJ, He CL, Sun T, Duan XJ, Sun Y, Xiong SJ.

Int J Mol Med. 2017 Jul;40(1):83-89. doi: 10.3892/ijmm.2017.2992. Epub 2017 May 16.

6.

Snail homolog 1 is involved in epithelial-mesenchymal transition-like processes in human glioblastoma cells.

Kühnöl CD, Würfel C, Staege MS, Kramm C.

Oncol Lett. 2017 May;13(5):3882-3888. doi: 10.3892/ol.2017.5875. Epub 2017 Mar 17.

7.

HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.

Nami B, Wang Z.

Cancers (Basel). 2017 Apr 26;9(5). pii: E40. doi: 10.3390/cancers9050040. Review.

8.

Intratumoral bidirectional transitions between epithelial and mesenchymal cells in triple-negative breast cancer.

Yamamoto M, Sakane K, Tominaga K, Gotoh N, Niwa T, Kikuchi Y, Tada K, Goshima N, Semba K, Inoue JI.

Cancer Sci. 2017 Jun;108(6):1210-1222. doi: 10.1111/cas.13246. Epub 2017 May 21.

9.

Functional role of ALK-related signal cascades on modulation of epithelial-mesenchymal transition and apoptosis in uterine carcinosarcoma.

Inoue H, Hashimura M, Akiya M, Chiba R, Saegusa M.

Mol Cancer. 2017 Feb 14;16(1):37. doi: 10.1186/s12943-017-0609-8.

10.

Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.

Pearlman RL, Montes de Oca MK, Pal HC, Afaq F.

Cancer Lett. 2017 Apr 10;391:125-140. doi: 10.1016/j.canlet.2017.01.029. Epub 2017 Jan 25. Review.

PMID:
28131904
11.

Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).

Martínez-Ramírez AS, Díaz-Muñoz M, Butanda-Ochoa A, Vázquez-Cuevas FG.

Purinergic Signal. 2017 Mar;13(1):1-12. doi: 10.1007/s11302-016-9550-3. Epub 2016 Nov 29. Review.

12.

Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer.

Kim MS, Jeong J, Seo J, Kim HS, Kim SJ, Jin W.

Sci Rep. 2016 Sep 22;6:33899. doi: 10.1038/srep33899.

13.

Epithelial-mesenchymal transition in tissue repair and fibrosis.

Stone RC, Pastar I, Ojeh N, Chen V, Liu S, Garzon KI, Tomic-Canic M.

Cell Tissue Res. 2016 Sep;365(3):495-506. doi: 10.1007/s00441-016-2464-0. Epub 2016 Jul 27. Review.

14.

Slug Is Increased in Vascular Remodeling and Induces a Smooth Muscle Cell Proliferative Phenotype.

Coll-Bonfill N, Peinado VI, Pisano MV, Párrizas M, Blanco I, Evers M, Engelmann JC, García-Lucio J, Tura-Ceide O, Meister G, Barberà JA, Musri MM.

PLoS One. 2016 Jul 21;11(7):e0159460. doi: 10.1371/journal.pone.0159460. eCollection 2016. Erratum in: PLoS One. 2016;11(8):e0162117.

15.

The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis.

Lebrun JJ.

ISRN Mol Biol. 2012 Dec 24;2012:381428. doi: 10.5402/2012/381428. eCollection 2012. Review.

16.

Extracting a low-dimensional description of multiple gene expression datasets reveals a potential driver for tumor-associated stroma in ovarian cancer.

Celik S, Logsdon BA, Battle S, Drescher CW, Rendi M, Hawkins RD, Lee SI.

Genome Med. 2016 Jun 10;8(1):66. doi: 10.1186/s13073-016-0319-7.

17.

Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.

Pan Y, Li J, Zhang Y, Wang N, Liang H, Liu Y, Zhang CY, Zen K, Gu H.

Sci Rep. 2016 May 13;6:25798. doi: 10.1038/srep25798.

18.

In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.

Hopper RK, Moonen JR, Diebold I, Cao A, Rhodes CJ, Tojais NF, Hennigs JK, Gu M, Wang L, Rabinovitch M.

Circulation. 2016 May 3;133(18):1783-94. doi: 10.1161/CIRCULATIONAHA.115.020617. Epub 2016 Apr 4.

20.

MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.

Wang C, Liu P, Wu H, Cui P, Li Y, Liu Y, Liu Z, Gou S.

Oncotarget. 2016 Mar 22;7(12):14912-24. doi: 10.18632/oncotarget.7482.

Supplemental Content

Support Center